We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Practice Makes Perfect in Lung Cancer Surgery

By HospiMedica International staff writers
Posted on 11 Nov 2008
A new study confirms that as with other surgical procedures, medical centers and individual doctors who perform larger volumes of lung cancer surgery have correspondingly lower mortality rates.

Researchers at Duke University (Durham, NC, USA) analyzed data from the U.S. More...
Nationwide Inpatient Sample--a publicly-available database of hospital admissions dating back 20 years and representing approximately 90% of hospitals in the United States--to examine death rates following three common types of surgery for lung cancer; pneumonectomy, in which the whole lung is removed; lobectomy, in which a third to half of the lung is removed; and segmental resection, in which a smaller portion of the lung is removed. In all, over 130,000 patient data samples were studied. The study results showed that mortality was highest, for all three procedures, at institutions which perform very few of these types of operations. In contrast, hospitals that performed 40 procedures or more per year had the lowest mortality rates. The researchers also found that the mortality in teaching hospitals was slightly lower than in non-teaching institutions. The study, scheduled for publication in the December 2008 edition of the journal Cancer Therapy, was published early online on the journal's website.

"Our study found that hospitals that do higher volumes of these types of surgeries have correspondingly lower mortality rates than those who do fewer of the procedures,” said lead author Andrew Shaw, M.D., an anesthesiologist at Duke. "This has important implications for both patients and doctors; patients should choose a center that does these procedures often, and doctors who are only doing a few of these a year should consider either growing their practices, or focusing their attention on other, less complex, types of surgery.”

"Patients are sometimes wary of having their surgery performed at a teaching institution because they think they may be operated on by an inexperienced trainee and this might lead to a poorer outcome,” Dr. Shaw added. "Actually, it appears that the outcomes at teaching hospitals are no worse than at non-teaching, or private, institutions.”

Related Links:
Duke University



Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Radiation Safety Barrier
RayShield Intensi-Barrier
VTE Prevention System
Flowtron ACS900
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.